Monthly Archives: April 2014

Pfizer’s real strategy is (mostly) tax-minimization

   Many observers were initially left scratching their heads over Pfizer’s pursuit of AstraZeneca, a company that has had major pipeline troubles of its own.  As more information has come out, Pfizer’s strategy is beginning to make sense.  They aren’t pursuing an old-style mega … Continue reading

Posted in Pharmaceutical Industry | Tagged , , , , | 1 Comment

Undeterred, Pfizer continues its mega merger strategy

Pfizer continues to stalk AstraZeneca, even as other firms abandon mega mergers.

Posted in Pharmaceutical Industry | Tagged , , | Leave a comment

A new tool for measuring National economic output

Starting April 25, the Bureau of Economic Analysis will begin reporting quarterly measurements of gross output. Gross output represents, roughly speaking, the total value of sales by producing enterprises (their turnover) in an accounting period (e.g. a quarter or a year), before subtracting the … Continue reading

Posted in Economics | Tagged , , | Leave a comment

Pharma megamergers — against the spirit of the times?

Here’s more on the Novartis-GSK-Lilly three way deal announced Tuesday.  As WSJ journalist Helen Thomas writes, the megamerger chill of dread felt when rumors of Pfizer’s stalking of AZ came to light last weekend may well be exorcized by this … Continue reading

Posted in Fixing Big Pharma Research, Pharmaceutical Industry | Tagged , , , , , , | 1 Comment

MST3K history as told by the participants

For those of a certain age and mindset, Mystery Science Theater 3000 is a cultural icon.  Here is a great recap of its history from Wired Magazine.  

Posted in Fun Science | Tagged , , , | Leave a comment

Pharma deal frenzy points to fundamental change in strategy

Pharmaceutical giants Novartis and GSK announced a large swap in business units on Tuesday, resulting in both companies becoming significantly more specialized — reversing their decades-long traditional strategies of greater diversification across product lines. The Wall Street Journal has more than … Continue reading

Posted in Pharmaceutical Industry | Tagged , , , , , | 1 Comment

Elon Musk on the Future of Design

Virtual reality interactions with 3-D CAD models, followed by laser-based metal sintering 3-D printing. Really cool stuff. SpaceX is using these tools to build their next generation reusable launch system. Elon Musk is Tony Stark. Or is it the other … Continue reading

Posted in Innovation, Space & Astronomy | Leave a comment

Good day for SpaceX

Friday SpaceX had a successful launch of a Dragon cargo capsule, and what looks like promising results from a controlled splashdown test of booster landing capability. Check out this video of the most recent land-based testing of the Falcon 9R: Really … Continue reading

Posted in Innovation, Space & Astronomy | Tagged , , , , | 1 Comment

Tom Sargent’s 12 lessons from economics

“Economics is organized common sense. Here is a short list of valuable lessons that our beautiful subject teaches.” 1. Many things that are desirable are not feasible. 2. Individuals and communities face trade-offs. 3. Other people have more information about … Continue reading

Posted in Economics | Tagged , , | Leave a comment

By 2017, over a million 3-D printers will be sold every year

3-D printers are expected to grow into a $5 billion market over the next few years.  Annually, printer shipments are projected to increase by 95% annually through 2017, by which time over a million units will ship per year.  More than two thirds of them will … Continue reading

Posted in 3-D Printing, Information Technology, Innovation | Tagged , | Leave a comment